FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Thomas Klingebiel

Research Profile

Procedures

Living Beings

Disorders

Concepts & Ideas

Co-author Network

Publications

TOP 3
Stanislaw Schmidt; Lars Tramsen; Susanne Perkhofer; Frauke Röger; Mitra Hanisch; Thomas Klingebiel; Ulrike Koehl; Cornelia Lass-Flörl; Thomas Lehrnbecher
Rhizopus oryzae hyphae are damaged by human natural killer (NK) cells, but suppress NK cell mediated immunity.
R Beier; Arndt Borkhardt; U Creutzig; Karoline Ehlert; Matthias Eyrich; Johann Greil; Bernd Gruhn; Rupert Handgretinger; W Holter; Thomas Klingebiel; Bernhard Kremens; Peter Lang; C Mauz-Körholz; R Meisel; I Müller; Christina Peters; Dirk Reinhardt; André Schrauder; Ansgar Schulz; F R Schuster; Petr Sedlacek; Brigitte Strahm; Karl-Walter Sykora; Wilhelm Wössmann; Martin Zimmermann; Michael H Albert; Peter Bader; M G Sauer
Allo-SCT using BU, CY and melphalan for children with AML in second CR.
Cornelia Eckert; Gabriele Escherich; Tom W L Groeneveld; Thomas Klingebiel; Christina Peters; Martin Schrappe; Karl Seeger; Arend von Stackelberg; Arndt Borkhardt; Günter Henze
Minimal residual disease after induction is the strongest predictor of prognosis in intermediate risk relapsed acute lymphoblastic leukaemia - long-term results of trial ALL-REZ BFM P95/96.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Thomas Klingebiel (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Stanislaw Schmidt; Lars Tramsen; Susanne Perkhofer; Frauke Röger; Mitra Hanisch; Thomas Klingebiel; Ulrike Koehl; Cornelia Lass-Flörl; Thomas Lehrnbecher
Rhizopus oryzae hyphae are damaged by human natural killer (NK) cells, but suppress NK cell mediated immunity.
Immunobiology 2013;218(7):939-44.
2013: R Beier; Arndt Borkhardt; U Creutzig; Karoline Ehlert; Matthias Eyrich; Johann Greil; Bernd Gruhn; Rupert Handgretinger; W Holter; Thomas Klingebiel; Bernhard Kremens; Peter Lang; C Mauz-Körholz; R Meisel; I Müller; Christina Peters; Dirk Reinhardt; André Schrauder; Ansgar Schulz; F R Schuster; Petr Sedlacek; Brigitte Strahm; Karl-Walter Sykora; Wilhelm Wössmann; Martin Zimmermann; Michael H Albert; Peter Bader; M G Sauer
Allo-SCT using BU, CY and melphalan for children with AML in second CR.
Bone marrow transplantation 2013;48(5):651-6.
2013: Cornelia Eckert; Gabriele Escherich; Tom W L Groeneveld; Thomas Klingebiel; Christina Peters; Martin Schrappe; Karl Seeger; Arend von Stackelberg; Arndt Borkhardt; Günter Henze
Minimal residual disease after induction is the strongest predictor of prognosis in intermediate risk relapsed acute lymphoblastic leukaemia - long-term results of trial ALL-REZ BFM P95/96.
European journal of cancer (Oxford, England : 1990) 2013;49(6):1346-55.
2013: Lars Tramsen; Frauke Roeger; Stanislaw Schmidt; Erhard Seifried; Halvard Boenig; Thomas Klingebiel; Cornelia Lass-Flörl; Jean-Paul Latgé; Thomas Lehrnbecher
Clinical-scale generation of multi-specific anti-fungal T cells targeting Candida, Aspergillus and mucormycetes.
Cytotherapy 2013;15(3):344-51.
2013: A Heinze; J L Hutton; Thomas Klingebiel; S Kloess; S Betz; M Bremm; O Ciocarlie; M C Elze; R Esser; Christoph Königs; M Serban; Ulrike Koehl
Age-matched dendritic cell subpopulations reference values in childhood.
Scandinavian journal of immunology 2013;77(3):213-20.
2013: Martin Benesch; Uta Bierbach; Alexander Claviez; Tobias Dantonello; Carsten Friedrich; Norbert Graf; Peter Kaatsch; Thomas Klingebiel; Rudolf Korinthenberg; Rolf-Dieter Kortmann; Ewa Koscielniak; Gabriele Kropshofer; Ivo Leuschner; Torsten Pietsch; Meinolf Suttorp; André O von Bueren; Nicolas von der Weid; Katja von Hoff; Stefan Rutkowski
Primary intracranial soft tissue sarcoma in children and adolescents: a cooperative analysis of the European CWS and HIT study groups.
Journal of neuro-oncology 2013;111(3):337-45.
2013: Thomas Lehrnbecher; Stanislaw Schmidt; Lars Tramsen; Thomas Klingebiel
Immunotherapy of invasive fungal infection in hematopoietic stem cell transplant recipients.
Frontiers in oncology 2013;3():17.
2012: U Thiel; I T von Lüttichau; A Wawer; Willi Woessmann; P Wolf; Peter Bader; F Blaeschke; A Borkhardt; M Bregni; Uta Dirksen; G Ehninger; Matthias Eyrich; B Gruhn; T G P Grunewald; R Handgretinger; E Holler; H Jürgens; C Klein; Thomas Klingebiel; E Koscielniak; P Lang; Hans-Jürgen Laws; C Mauz-Körholz; C Peters; G H S Richter; Paul G Schlegel; A H Schmidt; K-W Sykora; Stefan Burdach
Human leukocyte antigen distribution in German Caucasians with advanced Ewing's sarcoma.
Klinische Pädiatrie 2012;224(6):353-8.
2012: Thomas Klingebiel; Peter Bader
[Stem cell transplantation for acute leukemias: Balancing risks and benefits of different treatment methods].
Pharmazie in unserer Zeit 2012;41(3):222-7.
2012: Konrad Bochennek; S Erben; Ruth Esser; Wolfgang Glienke; Thomas Klingebiel; Thomas Lehrnbecher; Dirk Schwabe; J Soerensen; S Wehner; Peter Bader; Ulrike Koehl
Impact of minimal residual disease detection prior to autologous stem cell transplantation for post-transplant outcome in high risk neuroblastoma.
Klinische Pädiatrie 2012;224(3):139-42.
2012: Shinsuke Hirabayashi; Thomas Klingebiel; Franco Locatelli; Jessica Moetter; Charlotte M Niemeyer; Seishi Ogawa; Brigitte Schlegelberger; Jan Stary; Brigitte Strahm; Felicitas Thol; Marry M van den Heuvel-Eibrink; Marcin W Wlodarski; Marco Zecca; Irith Baumann; Eva Bergstraesser; Barbara De Moerloose; Michael Dworzak; Christian Flotho; Bernd Gruhn; Henrik Hasle; Michael Heuser
Spliceosomal gene aberrations are rare, coexist with oncogenic mutations, and are unlikely to exert a driver effect in childhood MDS and JMML.
Blood 2012;119(11):e96-9.
2012: Sylvia Borchers; Melanie Bremm; Elke Dammann; Matthias Eder; Ruth Esser; Arnold Ganser; Andrea Jarisch; Thomas Klingebiel; Thomas Lehrnbecher; Hans Martin; Brigitte Pabst; Gisbert Schneider; Michael Stadler; Eva M Weissinger; Benno Wölk; Meral Yildiz; Peter Bader; Ulrike Koehl
Sequential anti-cytomegalovirus response monitoring may allow prediction of cytomegalovirus reactivation after allogeneic stem cell transplantation.
PloS one 2012;7(12):e50248.
2012: Eva Rettinger; Andreas Volk; Winfried S Wels; Andre Willasch; Halvard Boenig; Simone Fulda; Thomas Klingebiel; Ewa Koscielniak; Hermann Kreyenberg; Selim Kuçi; Vida Meyer; Peter Bader
Cytotoxic Capacity of IL-15-Stimulated Cytokine-Induced Killer Cells Against Human Acute Myeloid Leukemia and Rhabdomyosarcoma in Humanized Preclinical Mouse Models.
Frontiers in oncology 2012;2():32.
2011: Eva Rettinger; Paul G Schlegel; Brigitte Strahm; Andre M Willasch; Wilhelm Woessmann; Michael H Albert; Arndt Borkhardt; Stefan Burdach; Bernd Gruhn; Wolfgang Holter; Thomas Klingebiel; Bernhard Kremens; Hermann Kreyenberg; Christine Mauz-Koerholz; Peter Bader
Preemptive immunotherapy in childhood acute myeloid leukemia for patients showing evidence of mixed chimerism after allogeneic stem cell transplantation.
Blood 2011;118(20):5681-8.
2011: Zyrafete Kuçi; Ralf Lieberz; Ralf Schubert; Susanne Zircher; Halvard Bönig; Reinhard Henschler; Thomas Klingebiel; Stefanie Koller; Selim Kuçi; Peter Bader
Mesenchymal stromal cells derived from CD271(+) bone marrow mononuclear cells exert potent allosuppressive properties.
Cytotherapy 2011;13(10):1193-204.
2011: Melanie Bremm; Gesine Bug; Annekathrin Heinze; Sabine Huenecke; Michael Kapinsky; Thomas Klingebiel; Thomas Lehrnbecher; Regine Mueller; Eva Ponstingl; Andrea Quaiser; Gisbert Schneider; Peter Bader; Claudia Brehm; Ulrike Koehl
Advanced flowcytometric analysis of regulatory T cells: CD127 downregulation early post stem cell transplantation and altered Treg/CD3(+)CD4(+)-ratio in severe GvHD or relapse.
Journal of immunological methods 2011;373(1-2):36-44.
2011: Peter Bader; Halvard Bönig; Matthias Dürken; Ruth Esser; Jörg Faber; Andrea Jarisch; Ulrike Koehl; Thomas Krenn; Eva Ponstingl; Harald Reinhardt; Jan Soerensen; Andre Willasch; Thomas Klingebiel
Rapid immune recovery and low TRM in haploidentical stem cell transplantation in children and adolescence using CD3/CD19-depleted stem cells.
Best practice & research. Clinical haematology 2011;24(3):331-7.
2011: Martin Schrappe; André Schrauder; Maria Grazia Valsecchi; Jacques J M van Dongen; Karl Welte; Martin Zimmermann; Maurizio Aricò; Claus R Bartram; Giuseppe Basso; Andrea Biondi; Barbara Buldini; Giovanni Cazzaniga; Michael Dworzak; Helmut Gadner; Thomas Klingebiel; Rolf Koehler; Franco Locatelli; Chiara Messina; Anja Möricke; Renate Panzer-Grümayer; Rosanna Parasole; Richard Ratei; Alfred Reiter; Beat W Schäfer; Valentino Conter
Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study.
Blood 2011;118(8):2077-84.
2011: Hermann Kreyenberg; Christine Mauz-Koerholz; Claudia Rossig; Paul G Schlegel; André Schrauder; Blanca Schuster; Daniel Stachel; Brigitte Strahm; Andre Willasch; Christina Bayer; James F Beck; Stefan Burdach; Tje Lin Chung; Monika Führer; Bernd Gruhn; Ernst Holler; Andrea Jarisch; Hartmut Kabisch; Thomas Klingebiel; Bernhard Kremens; Peter Bader
NOD2/CARD15 gene polymorphisms affect outcome in pediatric allogeneic stem cell transplantation.
Blood 2011;118(4):1181-4.
2011: Martin Benesch; Tobias Dantonello; Georg Ebetsberger; Eva Frey; Norbert Graf; Thomas Klingebiel; Udo Kontny; Bernhard Kremens; Ivo Leuschner; Franz Quehenberger; Marcus Schlemmer; Irene Schmid; Dominik T Schneider; Mareike Thielen; Christian Urban; Eva Wardelmann; Gabriele Amann; Ewa Koscielniak
Gastrointestinal stromal tumours in children and young adults: a clinicopathologic series with long-term follow-up from the database of the Cooperative Weichteilsarkom Studiengruppe (CWS).
European journal of cancer (Oxford, England : 1990) 2011;47(11):1692-8.
2011: Guido Seitz; Tobias M Dantonello; Christoph Int-Veen; Gunnar Blumenstock; Jan Godzinski; Thomas Klingebiel; Andreas Schuck; Ivo Leuschner; Ewa Koscielniak; Jörg Fuchs
Treatment efficiency, outcome and surgical treatment problems in patients suffering from localized embryonal bladder/prostate rhabdomyosarcoma: a report from the Cooperative Soft Tissue Sarcoma trial CWS-96.
Pediatric blood & cancer 2011;56(5):718-24.
2011: Thomas Lehrnbecher; Stanislaw Schmidt; Ulrike Koehl; Friedhelm R Schuster; Lutz Uharek; Thomas Klingebiel; Lars Tramsen
Adoptive antifungal T cell immunotherapy--into the clinic?
Medical mycology : official publication of the International Society for Human and Animal Mycology 2011;49 Suppl 1():S164-9.
2011: Holger Hebart; Claudia Lengerke; P Ljungman; C V Paya; Thomas Klingebiel; Juergen Loeffler; S Pfaffenrath; I Lewensohn-Fuchs; L Barkholt; Jürgen Tomiuk; Christoph Meisner; J Lunenberg; B Top; R R Razonable; R Patel; M R Litzow; Gerhard Jahn; Hermann Einsele
Prospective comparison of PCR-based vs late mRNA-based preemptive antiviral therapy for HCMV infection in patients after allo-SCT.
Bone marrow transplantation 2011;46(3):408-15.
2011: Claudia Brehm; Melanie Bremm; Ruth Esser; Sabine Huenecke; Thomas Klingebiel; Stephan Kloess; Hermann Kreyenberg; Heiko Muhl; Jakob R Passweg; Andrea Quaiser; Dirk Schwabe; Christian Seidl; Jan Soerensen; Peter Bader; Petra S A Becker; Ulrike Koehl
IL-2 stimulated but not unstimulated NK cells induce selective disappearance of peripheral blood cells: concomitant results to a phase I/II study.
PloS one 2011;6(11):e27351.
2011: Thomas Lehrnbecher; Stanislaw Schmidt; Lars Tramsen; Konrad Bochennek; Ulrike Koehl; Thomas Klingebiel
Immunotherapy against invasive fungal diseases in stem cell transplant recipients.
Immunological investigations 2011;40(7-8):839-52.
2011: Thorsten Simon; Barbara Hero; Andreas Faldum; Rupert Handgretinger; Martin Schrappe; Thomas Klingebiel; Frank Berthold
Long term outcome of high-risk neuroblastoma patients after immunotherapy with antibody ch14.18 or oral metronomic chemotherapy.
BMC cancer 2011;11():21.
2010: Leo Kager; Andreas Zoubek; Martin Dominkus; Susanna Lang; Nicole Bodmer; Gernot Jundt; Thomas Klingebiel; Heribert Jürgens; Helmut Gadner; Stefan S Bielack
Osteosarcoma in very young children: experience of the Cooperative Osteosarcoma Study Group.
Cancer 2010;116(22):5316-24.
2010: Stephan Kloess; Sabine Huenecke; Daniel Piechulek; Ruth Esser; Joachim Koch; Claudia Brehm; Jan Soerensen; Tanja Gardlowski; Andrea Brinkmann; Peter Bader; Jakob Passweg; Thomas Klingebiel; Dirk Schwabe; Ulrike Koehl
IL-2-activated haploidentical NK cells restore NKG2D-mediated NK-cell cytotoxicity in neuroblastoma patients by scavenging of plasma MICA.
European journal of immunology 2010;40(11):3255-67.
2010: Selim Kuçi; Eva Rettinger; Bernhard Voss; Gerrit Weber; Miriam Stais; Hermann Kreyenberg; Andre Willasch; Zyrafete Kuçi; Ewa Koscielniak; Stephan Klöss; Dorothee von Laer; Thomas Klingebiel; Peter Bader
Efficient lysis of rhabdomyosarcoma cells by cytokine-induced killer cells: implications for adoptive immunotherapy after allogeneic stem cell transplantation.
Haematologica 2010;95(9):1579-86.
2010: Inmaculada Martinez-Saguer; Eva Rusicke; Emel Aygören-Pürsün; Christine Heller; Thomas Klingebiel; Wolfhart Kreuz
Characterization of acute hereditary angioedema attacks during pregnancy and breast-feeding and their treatment with C1 inhibitor concentrate.
American journal of obstetrics and gynecology 2010;203(2):131.e1-7.
2010: Andrea Meinhardt; Birgit Burkhardt; Martin Zimmermann; Arndt Borkhardt; Udo Kontny; Thomas Klingebiel; Frank Berthold; Gritta Janka-Schaub; Christoph Klein; Edita Kabickova; Wolfram Klapper; Andishe Attarbaschi; Martin Schrappe; Alfred Reiter
Phase II window study on rituximab in newly diagnosed pediatric mature B-cell non-Hodgkin's lymphoma and Burkitt leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(19):3115-21.
2010: Dieter Klarmann; Christine Eggert; Christof Geisen; Sabine Becker; Erhard Seifried; Thomas Klingebiel; Wolfhart Kreuz
Association of ABO(H) and I blood group system development with von Willebrand factor and Factor VIII plasma levels in children and adolescents.
Transfusion 2010;50(7):1571-80.
2010: Selim Kuçi; Zyrafete Kuçi; Hermann Kreyenberg; Erika Deak; Kathrin Pütsch; Sabine Huenecke; Chandrasekhar Amara; Stefanie Koller; Eva Rettinger; Manuel Grez; Ulrike Koehl; Hatixhe Latifi-Pupovci; Reinhard Henschler; Torsten Tonn; Dorothee von Laer; Thomas Klingebiel; Peter Bader
CD271 antigen defines a subset of multipotent stromal cells with immunosuppressive and lymphohematopoietic engraftment-promoting properties.
Haematologica 2010;95(4):651-9.
2010: M Koenig; S Huenecke; E Salzmann-Manrique; Ruth Esser; R Quaritsch; D Steinhilber; H H Radeke; Hans Martin; Peter Bader; Thomas Klingebiel; Dirk Schwabe; G Schneider; Thomas Lehrnbecher; A Orth; Ulrike Koehl
Multivariate analyses of immune reconstitution in children after allo-SCT: risk-estimation based on age-matched leukocyte sub-populations.
Bone marrow transplantation 2010;45(4):613-21.
2010: Sabine Huenecke; Stefanie-Yvonne Zimmermann; Stephan Kloess; Ruth Esser; Andrea Brinkmann; Lars Tramsen; Melanie Koenig; Stephanie Erben; Christian Seidl; Torsten Tonn; Angelika Eggert; Alexander Schramm; Peter Bader; Thomas Klingebiel; Thomas Lehrnbecher; Jakob Robert Passweg; Jan Soerensen; Dirk Schwabe; Ulrike Koehl
IL-2-driven regulation of NK cell receptors with regard to the distribution of CD16+ and CD16- subpopulations and in vivo influence after haploidentical NK cell infusion.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2010;33(2):200-10.
2010: Anja Möricke; Martin Zimmermann; Alfred Reiter; Günter Henze; André Schrauder; Helmut Gadner; Wolf-Dieter Ludwig; J Ritter; Jochen Harbott; Georg Mann; Thomas Klingebiel; Felix Zintl; C Niemeyer; Bernhard Kremens; Felix Niggli; Dietrich Niethammer; Karl Welte; Martin Stanulla; E Odenwald; Hansjörg Riehm; Martin Schrappe
Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000.
Leukemia 2010;24(2):265-84.
2010: Inmaculada Martinez-Saguer; Eva Rusicke; Emel Aygören-Pürsün; Nils von Hentig; Thomas Klingebiel; Wolfhart Kreuz
Pharmacokinetic analysis of human plasma-derived pasteurized C1-inhibitor concentrate in adults and children with hereditary angioedema: a prospective study.
Transfusion 2010;50(2):354-60.
2010: Emel Aygören-Pürsün; Inmaculada Martinez-Saguer; Eva Rusicke; Thomas Klingebiel; Wolfhart Kreuz
On demand treatment and home therapy of hereditary angioedema in Germany - the Frankfurt experience.
Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 2010;6(1):21.
2010: A Willasch; S Eing; G Weber; Selim Kuçi; G Schneider; J Soerensen; Andrea Jarisch; E Rettinger; Ulrike Koehl; Thomas Klingebiel; Hermann Kreyenberg; Peter Bader
Enrichment of cell subpopulations applying automated MACS technique: purity, recovery and applicability for PCR-based chimerism analysis.
Bone marrow transplantation 2010;45(1):181-9.
2009: S Wehner; J Soerensen; Dirk Schwabe; L Tramsen; R Quaritsch; Ruth Esser; Thomas Klingebiel; Ulrike Koehl
10-Parameter flow cytometry as a new tool to improve diagnosis and MRD follow-up of acute leukemias.
Klinische Pädiatrie 2009;221(6):393-5.
2009: Wolfhart Kreuz; Inmaculada Martinez-Saguer; Emel Aygören-Pürsün; Eva Rusicke; Christine Heller; Thomas Klingebiel
C1-inhibitor concentrate for individual replacement therapy in patients with severe hereditary angioedema refractory to danazol prophylaxis.
Transfusion 2009;49(9):1987-95.
2009: G Weber; J Karbach; Selim Kuçi; Hermann Kreyenberg; A Willasch; Ewa Koscielniak; Torsten Tonn; Thomas Klingebiel; Winfried S Wels; E Jäger; Peter Bader
WT1 peptide-specific T cells generated from peripheral blood of healthy donors: possible implications for adoptive immunotherapy after allogeneic stem cell transplantation.
Leukemia 2009;23(9):1634-42.
2009: Christoph Kessel; Wolfhart Kreuz; Katharina Klich; Karin Becker-Peters; Frank Vorpahl; Ursula Dietrich; Thomas Klingebiel; Christoph Königs
Multimerization of peptide mimotopes for blocking of factor VIII neutralizing antibodies.
ChemMedChem 2009;4(8):1364-70.
2009: Selim Kuçi; Zyrafete Kuçi; Hatixhe Latifi-Pupovci; Dietrich Niethammer; Rupert Handgretinger; Michael Schumm; Gernot Bruchelt; Peter Bader; Thomas Klingebiel
Adult stem cells as an alternative source of multipotential (pluripotential) cells in regenerative medicine.
Current stem cell research & therapy 2009;4(2):107-17.
2009: Holger Hebart; Lena Klingspor; Thomas Klingebiel; Juergen Loeffler; J Tollemar; P Ljungman; H Wandt; K Schaefer-Eckart; H J Dornbusch; Christoph Meisner; Corinna Engel; N Stenger; T Mayer; O Ringden; Hermann Einsele
A prospective randomized controlled trial comparing PCR-based and empirical treatment with liposomal amphotericin B in patients after allo-SCT.
Bone marrow transplantation 2009;43(7):553-61.
2009: Peter Bader; Hermann Kreyenberg; Günter H R Henze; Cornelia Eckert; Miriam Reising; Andre Willasch; Andrea Barth; Arndt Borkhardt; Christina Peters; Rupert Handgretinger; Karl-Walter Sykora; Wolfgang Holter; Hartmut Kabisch; Thomas Klingebiel; Arend von Stackelberg
Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(3):377-84.
2009: L Tramsen; Ulrike Koehl; Torsten Tonn; Jean-Paul Latgé; Friedhelm R Schuster; A Borkhardt; L Uharek; R Quaritsch; Olaf Beck; Erhard Seifried; Thomas Klingebiel; Thomas Lehrnbecher
Clinical-scale generation of human anti-Aspergillus T cells for adoptive immunotherapy.
Bone marrow transplantation 2009;43(1):13-9.
2008: Christoph Kessel; Christoph Königs; Richard Linde; Carmen Escuriola-Ettinghausen; Hildegard Stoll; Thomas Klingebiel; Ursula Dietrich; Wolfhart Kreuz
Humoral immune responsiveness to a defined epitope on factor VIII before and after B cell ablation with rituximab.
Molecular immunology 2008;46(1):8-15.
2008: Thomas Klingebiel; Dirk Reinhardt; Peter Bader
Place of HSCT in treatment of childhood AML.
Bone marrow transplantation 2008;42 Suppl 2():S7-9.
2008: Doreen Munkelt; Ulrike Koehl; Stephan Kloess; Stefanie-Yvonne Zimmermann; Rabiá El Kalaäoui; Sibylle Wehner; Dirk Schwabe; Thomas Lehrnbecher; Ralf Schubert; Joerg Kreuter; Thomas Klingebiel; Ruth Esser
Cytotoxic effects of treosulfan and busulfan against leukemic cells of pediatric patients.
Cancer chemotherapy and pharmacology 2008;62(5):821-30.
2008: Thomas Klingebiel; Peter Bader
Delayed lymphocyte infusion in children given SCT.
Bone marrow transplantation 2008;41 Suppl 2():S23-6.
2008: Tobias M Dantonello; Christoph Int-Veen; Ivo Leuschner; Andreas Schuck; Rhoikos Furtwaengler; Alexander Claviez; Dominik Schneider; Thomas Klingebiel; Stefan S Bielack; Ewa Koscielniak
Mesenchymal chondrosarcoma of soft tissues and bone in children, adolescents, and young adults: experiences of the CWS and COSS study groups.
Cancer 2008;112(11):2424-31.
2008: Adriana Balduzzi; Paola de Lorenzo; André Schrauder; Valentino Conter; Cornelio Uderzo; Christina Peters; Thomas Klingebiel; Jan Stary; Maria S Felice; Edina Magyarosy; Martin Schrappe; Giorgio Dini; Helmut Gadner; Maria Grazia Valsecchi
Eligibility for allogeneic transplantation in very high risk childhood acute lymphoblastic leukemia: the impact of the waiting time.
Haematologica 2008;93(6):925-9.
2008: Olaf Beck; Ulrike Koehl; Lars Tramsen; Sabine Mousset; Jean-Paul Latgé; Katrin Müller; Dirk Schwabe; Peter Bader; Thomas Klingebiel; Thomas Lehrnbecher
Enumeration of functionally active anti-Aspergillus T-cells in human peripheral blood.
Journal of immunological methods 2008;335(1-2):41-5.
2008: Sabine Huenecke; Michael Behl; Carla Fadler; Stefanie Y Zimmermann; Konrad Bochennek; Lars Tramsen; Ruth Esser; Dieter Klarmann; Martina Kamper; Alexandra Sattler; Dorothee von Laer; Thomas Klingebiel; Thomas Lehrnbecher; Ulrike Koehl
Age-matched lymphocyte subpopulation reference values in childhood and adolescence: application of exponential regression analysis.
European journal of haematology 2008;80(6):532-9.
2008: Anja Möricke; Alfred Reiter; Martin Zimmermann; Helmut Gadner; Martin Stanulla; Michael Dördelmann; Lutz Löning; Rita Beier; Wolf-Dieter Ludwig; Richard Ratei; Jochen Harbott; Joachim Boos; Georg Mann; Felix Niggli; Andreas Feldges; Günter Henze; Karl Welte; Jörn D Beck; Thomas Klingebiel; Charlotte Niemeyer; Felix Zintl; Udo Bode; Christian Urban; Helmut Wehinger; Dietrich Niethammer; Hansjörg Riehm; Martin Schrappe
Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95.
Blood 2008;111(9):4477-89.
2008: Thomas Klingebiel; Joachim Boos; Florian Beske; Erika Hallmen; Christoph Int-Veen; Tobias Dantonello; Jörn Treuner; Helmut Gadner; Ildiko Marky; Bernarda Kazanowska; Ewa Koscielniak
Treatment of children with metastatic soft tissue sarcoma with oral maintenance compared to high dose chemotherapy: report of the HD CWS-96 trial.
Pediatric blood & cancer 2008;50(4):739-45.
2008: Thomas Lehrnbecher; Ulrike Koehl; Boris Wittekindt; Konrad Bochennek; Lars Tramsen; Thomas Klingebiel; STEPHEN CHANOCK
Changes in host defence induced by malignancies and antineoplastic treatment: implication for immunotherapeutic strategies.
The lancet oncology 2008;9(3):269-78.
2008: Arend von Stackelberg; Reinhard Hartmann; Christoph Bührer; Rüdiger Fengler; Gritta E Janka-Schaub; Alfred Reiter; Georg Mann; Kjeld Schmiegelow; Richard Ratei; Thomas Klingebiel; Jörg Ritter; Günter Henze
High-dose compared with intermediate-dose methotrexate in children with a first relapse of acute lymphoblastic leukemia.
Blood 2008;111(5):2573-80.
2008: Gabriele Hollatz; Manuel Grez; S Mastaglio; R Quaritsch; S Huenecke; Fabio Ciceri; Chiara Bonini; Ruth Esser; Thomas Klingebiel; J Kreuter; Ulrike Koehl
T cells for suicide gene therapy: activation, functionality and clinical relevance.
Journal of immunological methods 2008;331(1-2):69-81.
2008: Selim Kuçi; Zyrafete Kuçi; Susanne Schmid; Guido Seitz; I Müller; Andreas Dufke; T Leimig; G Murti; Roland Jurecic; Michael Schumm; Peter Lang; Gernot Bruchelt; Peter Bader; Thomas Klingebiel; Dietrich Niethammer; Rupert Handgretinger
Efficient in vitro generation of adult multipotent cells from mobilized peripheral blood CD133+ cells.
Cell proliferation 2008;41(1):12-27.
2008: Ulrike Koehl; Konrad Bochennek; Ruth Esser; A Brinkmann; R Quaritsch; M Becker; J Soerensen; Peter Bader; Dirk Schwabe; Thomas Klingebiel; J Fischer; Stefanie-Yvonne Zimmermann
ISHAGE-based single-platform flowcytometric analysis for measurement of absolute viable T cells in fresh or cryopreserved products: CD34/CD133 selected or CD3/CD19 depleted stem cells, DLI and purified CD56+CD3- NK cells.
International journal of hematology 2008;87(1):98-105.
2008: Peter Lang; Ingo Mueller; Johann Greil; Peter Bader; Michael Schumm; Matthias Pfeiffer; Walter Hoelle; Thomas Klingebiel; Frank Heinzelmann; Claus Belka; Paul G Schlegel; Bernhard Kremens; Willi Woessmann; Rupert Handgretinger
Retransplantation with stem cells from mismatched related donors after graft rejection in pediatric patients.
Blood cells, molecules & diseases 2008;40(1):33-9.
2008: Harald Reinhard; Thomas Klingebiel; Peter Lang; Peter Bader; Dietrich Niethammer; Norbert Graf
Stem cell transplantation for polycythemia vera.
Pediatric blood & cancer 2008;50(1):124-6.
2007: Konrad Bochennek; Boris Wittekindt; Stefanie-Yvonne Zimmermann; Thomas Klingebiel
More than mere games: a review of card and board games for medical education.
Medical teacher 2007;29(9):941-8.
2007: Thomas Lehrnbecher; J Kaiser; Domenica Varwig; J Ritter; A H Groll; Ursula Creutzig; Thomas Klingebiel; Dirk Schwabe
Antifungal usage in children undergoing intensive treatment for acute myeloid leukemia: analysis of the multicenter clinical trial AML-BFM 93.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2007;26(10):735-8.
2007: Stephan Klöss; Konrad Bochennek; Sabine Huenecke; Stefanie-Yvonne Zimmermann; Selim Kuçi; Tina Müller; Winfried S Wels; Thomas Klingebiel; Ruth Esser; Ulrike Koehl
A novel five-colour flow cytometric assay to determine NK cell cytotoxicity against neuroblastoma and other adherent tumour cells.
Journal of immunological methods 2007;325(1-2):140-7.
2007: Lars Tramsen; Olaf Beck; Friedhelm R Schuster; Klaus-Peter Hunfeld; Jean-Paul Latgé; Jacqueline Sarfati; Frauke Röger; Thomas Klingebiel; Ulrike Koehl; Thomas Lehrnbecher
Generation and characterization of anti-Candida T cells as potential immunotherapy in patients with Candida infection after allogeneic hematopoietic stem-cell transplant.
The Journal of infectious diseases 2007;196(3):485-92.
2007: F Beske; S Modrow; Jan Sörensen; H Schmidt; Susanne Kriener; R Allwinn; Thomas Klingebiel; Dirk Schwabe; Thomas Lehrnbecher
Parvovirus B19 pneumonia in a child undergoing allogeneic hematopoietic stem cell transplantation.
Bone marrow transplantation 2007;40(1):89-91.
2007: S Parbel; Stefan Vlaho; Boris Gebhardt; Luciana Porto; Elke Hattingen; Thomas Klingebiel; Hansjosef Böhles; Matthias Kieslich
[Diagnostic difficulties in encephalitis and glioma].
Klinische Pädiatrie 2007;219(4):222-4.
2007: Eric Kowarz; Thomas Burmeister; L Lo Nigro; M W J C Jansen; E Delabesse; Thomas Klingebiel; Theo Dingermann; Claus Meyer; Rolf Marschalek
Complex MLL rearrangements in t(4;11) leukemia patients with absent AF4.MLL fusion allele.
Leukemia 2007;21(6):1232-8.
2007: Georg Hempel; Doris Oechtering; Claudia Lanvers-Kaminsky; Thomas Klingebiel; Josef Vormoor; Bernd Gruhn; Joachim Boos
Cytotoxicity of dimethylacetamide and pharmacokinetics in children receiving intravenous busulfan.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(13):1772-8.
2007: Ayami Yoshimi; Irith Baumann; Monika Führer; Eva Bergsträsser; Ulrich Göbel; Karl-Walter Sykora; Thomas Klingebiel; Ute Gross-Wieltsch; Marry M van den Heuvel-Eibrink; Alexandra Fischer; Peter Nöllke; Charlotte Niemeyer
Immunosuppressive therapy with anti-thymocyte globulin and cyclosporine A in selected children with hypoplastic refractory cytopenia.
Haematologica 2007;92(3):397-400.
2007: Ulrike Koehl; Konrad Bochennek; Stefanie-Yvonne Zimmermann; Thomas Lehrnbecher; Jan Sörensen; Ruth Esser; C Andreas; C Kramm; Hans-Peter Grüttner; E Falkenberg; A Orth; Peter Bader; Dirk Schwabe; Thomas Klingebiel
Immune recovery in children undergoing allogeneic stem cell transplantation: absolute CD8+ CD3+ count reconstitution is associated with survival.
Bone marrow transplantation 2007;39(5):269-78.
2007: Ayami Yoshimi; M Mohamed; Marc Bierings; Christian Urban; Elisabeth Korthof; Marco Zecca; Karl-Walter Sykora; Ulrich Duffner; Monika M Trebo; Susanne Matthes-Martin; Petr Sedlacek; Thomas Klingebiel; Peter Lang; Monika Führer; Alexander Claviez; Wilhelm Wössmann; Andrea Pession; J Arvidson; Aengus O'Marcaigh; Marry M van den Heuvel-Eibrink; Jan Starý; Henrik Hasle; Peter Nöllke; Franco Locatelli; Charlotte M Niemeyer
Second allogeneic hematopoietic stem cell transplantation (HSCT) results in outcome similar to that of first HSCT for patients with juvenile myelomonocytic leukemia.
Leukemia 2007;21(3):556-60.
2007: Claus Meyer; Thomas Burmeister; Sabine Strehl; B Schneider; D Hubert; O Zach; Oskar A Haas; Thomas Klingebiel; Theo Dingermann; Rolf Marschalek
Spliced MLL fusions: a novel mechanism to generate functional chimeric MLL-MLLT1 transcripts in t(11;19)(q23;p13.3) leukemia.
Leukemia 2007;21(3):588-90.
2007: Andre Willasch; Gaby Schneider; Britta Sofia Reincke; Nona Shayegi; Hermann Kreyenberg; Selim Kuci; Gerrit Weber; Bert Van Der Reijden; Dietrich Niethammer; Thomas Klingebiel; Peter Bader
Sequence polymorphism systems for quantitative real-time polymerase chain reaction to characterize hematopoietic chimerism-high informativity and sensitivity as well as excellent reproducibility and precision of measurement.
Laboratory hematology : official publication of the International Society for Laboratory Hematology 2007;13(3):73-84.
2006: André Schrauder; Alfred Reiter; Helmut Gadner; Dietrich Niethammer; Thomas Klingebiel; Bernhard Kremens; Christina Peters; Wolfram Ebell; Martin Zimmermann; Felix Niggli; Wolf-Dieter Ludwig; Hansjörg Riehm; Karl Welte; Martin Schrappe
Superiority of allogeneic hematopoietic stem-cell transplantation compared with chemotherapy alone in high-risk childhood T-cell acute lymphoblastic leukemia: results from ALL-BFM 90 and 95.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(36):5742-9.
2006: Thomas Klingebiel; Peter Bader; G Hollatz; Ulrike Koehl; Thomas Lehrnbecher; Roland Meisel; Dagmar Dilloo
Immunotherapy in children: report from the Reisensburg-Symposium October 20-22, 2004 and recent advances.
Klinische Pädiatrie 2006;218(6):355-65.
2006: Claus Meyer; Eric Kowarz; Björn Schneider; Clarissa Oehm; Thomas Klingebiel; Theo Dingermann; Rolf Marschalek
Genomic DNA of leukemic patients: target for clinical diagnosis of MLL rearrangements.
Biotechnology journal 2006;1(6):656-63.
2006: Andre Willasch; Walter Hoelle; Hermann Kreyenberg; Dietrich Niethammer; Rupert Handgretinger; Peter Lang; James F Beck; Thomas Klingebiel; Peter Bader
Outcome of allogeneic stem cell transplantation in children with non-malignant diseases.
Haematologica 2006;91(6):788-94.
2006: Thomas Lehrnbecher; Martina Becker; Dirk Schwabe; Ulrike Köhl; Susanne Kriener; Klaus-Peter Hunfeld; Helga Schmidt; Peter A Beyer; Thomas Klingebiel; Peter Bader; Jan Sörensen
Primary intestinal aspergillosis after high-dose chemotherapy and autologous stem cell rescue.
The Pediatric infectious disease journal 2006;25(5):465-6.
2006: Olaf Beck; Max S Topp; Ulrike Koehl; Emmanuel Roilides; Maria Simitsopoulou; Mitra Hanisch; Jacqueline Sarfati; Jean-Paul Latgé; Thomas Klingebiel; Hermann Einsele; Thomas Lehrnbecher
Generation of highly purified and functionally active human TH1 cells against Aspergillus fumigatus.
Blood 2006;107(6):2562-9.
2006: Olaf Beck; Christian Seidl; Thomas Lehrnbecher; Hermann Kreyenberg; Dirk Schwabe; Thomas Klingebiel; Erhard Seifried; Peter Bader; Ulrike Koehl
Quantification of chimerism within peripheral blood, bone marrow and purified leukocyte subsets: comparison of singleplex and multiplex PCR amplification of short tandem repeat (STR) loci.
European journal of haematology 2006;76(3):237-44.
2006: Sibylle Loibl; Gunter von Minckwitz; Karin Gwyn; Paul Ellis; Jens-Uwe Blohmer; Brigitte Schlegelberger; Monika Keller; Sebastian Harder; Richard L Theriault; Diana Crivellari; Thomas Klingebiel; Frank Louwen; Manfred Kaufmann
Breast carcinoma during pregnancy. International recommendations from an expert meeting.
Cancer 2006;106(2):237-46.
2006: Jan Sörensen; Martina Becker; Luciana Porto; Evelyn Lambrecht; Tobias Schuster; Florian Beske; Volker Rickerts; Thomas Klingebiel; Thomas Lehrnbecher
Rhinocerebral zygomycosis in a young girl undergoing allogeneic stem cell transplantation for severe aplastic anaemia.
Mycoses 2006;49 Suppl 1():31-6.
2005: Ulrike Koehl; Ruth Esser; Stefanie-Yvonne Zimmermann; Torsten Tonn; Rouslan Kotchetkov; T Bartling; Jan Sörensen; Hans-Peter Grüttner; Peter Bader; Erhard Seifried; Hans Martin; P Lang; Jakob R Passweg; Thomas Klingebiel; Dirk Schwabe
Ex vivo expansion of highly purified NK cells for immunotherapy after haploidentical stem cell transplantation in children.
Klinische Pädiatrie 2005;217(6):345-50.
2005: Tobias Feuchtinger; Celine Richard; Matthias Pfeiffer; F Neuhäuser; J Lücke; Rupert Handgretinger; Johann Greil; Peter Bader; Thomas Klingebiel; Paul G Schlegel; Gerhard Jahn; Dietrich Niethammer; Peter Lang
Adenoviral infections after transplantation of positive selected stem cells from haploidentical donors in children: an update.
Klinische Pädiatrie 2005;217(6):339-44.
2005: Peter Lang; Michael Schumm; Johann Greil; Peter Bader; Thomas Klingebiel; I Müller; Tobias Feuchtinger; Matthias Pfeiffer; Paul G Schlegel; Dietrich Niethammer; Rupert Handgretinger
A comparison between three graft manipulation methods for haploidentical stem cell transplantation in pediatric patients: preliminary results of a pilot study.
Klinische Pädiatrie 2005;217(6):334-8.
2005: Thomas Lehrnbecher; Toralf Bernig; Mitra Hanisch; Ulrike Koehl; M Behl; Dirk Reinhardt; Ursula Creutzig; Thomas Klingebiel; STEPHEN CHANOCK; Dirk Schwabe
Common genetic variants in the interleukin-6 and chitotriosidase genes are associated with the risk for serious infection in children undergoing therapy for acute myeloid leukemia.
Leukemia 2005;19(10):1745-50.
2005: Konrad Bochennek; C Andreas; C Margraf; H Stahlkamp; Stefanie-Yvonne Zimmermann; Ruth Esser; Dirk Schwabe; Thomas Klingebiel; Hans-Peter Grüttner; Ulrike Koehl
Hourly monitoring of circulating CD34+ cells to optimize timing of autologous apheresis in pediatric patients.
Bone marrow transplantation 2005;36(6):481-9.
2005: Ayami Yoshimi; Peter Bader; Susanne Matthes-Martin; Jan Starý; Petr Sedlacek; Ulrich Duffner; Thomas Klingebiel; Dagmar Dilloo; Wolfgang Holter; Felix Zintl; Bernhard Kremens; Karl-Walter Sykora; Christian Urban; Henrik Hasle; Elisabeth Korthof; Tom Révész; Alain Fischer; Peter Nöllke; Franco Locatelli; Charlotte M Niemeyer
Donor leukocyte infusion after hematopoietic stem cell transplantation in patients with juvenile myelomonocytic leukemia.
Leukemia 2005;19(6):971-7.
2005: Ayami Yoshimi; Charlotte M Niemeyer; Viktoria Bohmer; Ulrich Duffner; Brigitte Strahm; Hermann Kreyenberg; Dagmar Dilloo; Felix Zintl; Alexander Claviez; Wilhelm Wössmann; Bernhard Kremens; Wolfgang Holter; Dietrich Niethammer; James F Beck; Udo Kontny; Peter Nöllke; Thomas Klingebiel; Peter Bader
Chimaerism analyses and subsequent immunological intervention after stem cell transplantation in patients with juvenile myelomonocytic leukaemia.
British journal of haematology 2005;129(4):542-9.
2005: Thomas Klingebiel; Peter Lang; Michael Schumm; Ulrike Koehl; Peter Bader; Dirk Schwabe; Paul G Schlegel; Matthias Eyrich; Johann Greil; James F Beck; Dietrich Niethammer; Rupert Handgretinger
Experiences with haploidentical stem cell transplantation in children with acute lymphoblastic leukemia.
Pathologie-biologie 2005;53(3):159-61.
2005: Michael B Ranke; C Philipp Schwarze; RE Dopfer; Thomas Klingebiel; Hans Scheel-Walter; Peter Lang; Dietrich Niethammer
Late effects after stem cell transplantation (SCT) in children--growth and hormones.
Bone marrow transplantation 2005;35 Suppl 1():S77-81.
2005: Peter Bader; Charlotte Niemeyer; Andre Willasch; Hermann Kreyenberg; Brigitte Strahm; Bernhard Kremens; Bernd Gruhn; Dagmar Dilloo; Josef Vormoor; Peter Lang; Dietrich Niethammer; Thomas Klingebiel; James F Beck
Children with myelodysplastic syndrome (MDS) and increasing mixed chimaerism after allogeneic stem cell transplantation have a poor outcome which can be improved by pre-emptive immunotherapy.
British journal of haematology 2005;128(5):649-58.
2005: Doris Oechtering; Brunhild Schiltmeyer; Georg Hempel; Matthias Schwab; Gudrun Würthwein; Thomas E Mürdter; Thomas Klingebiel; Josef Vormoor; Bernd Gruhn; Gudrun Fleischack; Joachim Boos
Toxicity and pharmacokinetics of i.v. busulfan in children before stem cell transplantation.
Anti-cancer drugs 2005;16(3):337-44.
2005: Willi Woessmann; Kathrin Seidemann; Georg Mann; Martin Zimmermann; Birgit Burkhardt; Ilske Oschlies; Wolf-Dieter Ludwig; Thomas Klingebiel; Norbert Graf; Bernd Gruhn; Heribert Juergens; Felix Niggli; Reza Parwaresch; Helmut Gadner; Hansjörg Riehm; Martin Schrappe; Alfred Reiter
The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95.
Blood 2005;105(3):948-58.
2005: Beate Kempf-Bielack; Stefan S Bielack; Heribert Jürgens; Detlev Branscheid; Wolfgang E Berdel; G Ulrich Exner; Ulrich Göbel; Knut Helmke; Gernot Jundt; Hartmut Kabisch; Matthias Kevric; Thomas Klingebiel; Rainer Kotz; Rainer Maas; Rudolf Schwarz; Michael Semik; Jörn Treuner; Andreas Zoubek; Kurt Winkler
Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(3):559-68.
2005: Claus Meyer; Bjoern Schneider; Martin Reichel; Sieglinde Angermueller; Sabine Strehl; Susanne Schnittger; Claudia Schoch; M W J C Jansen; Jacques J M van Dongen; Rob Pieters; Oskar A Haas; Theo Dingermann; Thomas Klingebiel; Rolf Marschalek
Diagnostic tool for the identification of MLL rearrangements including unknown partner genes.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(2):449-54.
2005: Stefanie-Yvonne Zimmermann; Ruth Esser; Eckhard Rohrbach; Thomas Klingebiel; Ulrike Koehl
A novel four-colour flow cytometric assay to determine natural killer cell or T-cell-mediated cellular cytotoxicity against leukaemic cells in peripheral or bone marrow specimens containing greater than 20% of normal cells.
Journal of immunological methods 2005;296(1-2):63-76.
2005: Ewa Koscielniak; Ute Gross-Wieltsch; Jörn Treuner; Peter Winkler; Thomas Klingebiel; Peter Lang; Peter Bader; Dietrich Niethammer; Rupert Handgretinger
Graft-versus-Ewing sarcoma effect and long-term remission induced by haploidentical stem-cell transplantation in a patient with relapse of metastatic disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(1):242-4.
2005: Peter Bader; Dietrich Niethammer; Andre Willasch; Hermann Kreyenberg; Thomas Klingebiel
How and when should we monitor chimerism after allogeneic stem cell transplantation?
Bone marrow transplantation 2005;35(2):107-19.
2004: Olaf Beck; Walter Josef Fassbender; Peter A Beyer; Susanne Kriener; H P H Neumann; Thomas Klingebiel; Thomas Lehrnbecher
Pheochromocytoma in childhood: implication for further diagnostic procedures.
Acta paediatrica (Oslo, Norway : 1992) 2004;93(12):1630-4.
2004: Peter Lang; Johann Greil; Peter Bader; Rupert Handgretinger; Thomas Klingebiel; Michael Schumm; Paul G Schlegel; Tobias Feuchtinger; Matthias Pfeiffer; Hans Scheel-Walter; Monika Führer; David Martin; Dietrich Niethammer
Long-term outcome after haploidentical stem cell transplantation in children.
Blood cells, molecules & diseases 2004;33(3):281-7.
2004: Ulrike Koehl; Jan Sörensen; Ruth Esser; Stefanie-Yvonne Zimmermann; Hans-Peter Grüttner; Torsten Tonn; Christian Seidl; Erhard Seifried; Thomas Klingebiel; Dirk Schwabe
IL-2 activated NK cell immunotherapy of three children after haploidentical stem cell transplantation.
Blood cells, molecules & diseases 2004;33(3):261-6.
2004: Thomas Klingebiel; Rupert Handgretinger; Peter Lang; Peter Bader; Dietrich Niethammer
Haploidentical transplantation for acute lymphoblastic leukemia in childhood.
Blood reviews 2004;18(3):181-92.
2004: Peter Bader; Hermann Kreyenberg; Walter Hoelle; Gregor Dueckers; Rupert Handgretinger; Peter Lang; Bernhard Kremens; Dagmar Dilloo; Karl-Walter Sykora; Martin Schrappe; Charlotte Niemeyer; Arend von Stackelberg; Bernd Gruhn; Günter Henze; Johann Greil; Dietrich Niethammer; Klaus Dietz; James F Beck; Thomas Klingebiel
Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation: possible role for pre-emptive immunotherapy?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(9):1696-705.
2004: Peter Bader; Hermann Kreyenberg; Walter Hoelle; Gregor Dueckers; Bernhard Kremens; Dagmar Dilloo; Karl-Walter Sykora; Charlotte Niemeyer; Dirk Reinhardt; Josef Vormoor; Bernd Gruhn; Peter Lang; Johann Greil; Rupert Handgretinger; Dietrich Niethammer; Thomas Klingebiel; James F Beck
Increasing mixed chimerism defines a high-risk group of childhood acute myelogenous leukemia patients after allogeneic stem cell transplantation where pre-emptive immunotherapy may be effective.
Bone marrow transplantation 2004;33(8):815-21.
2004: Thomas Lehrnbecher; Gudrun Fleischhack; Mitra Hanisch; Frank Deinlein; Arne Simon; Toralf Bernig; STEPHEN CHANOCK; Thomas Klingebiel
Circulating levels and promoter polymorphisms of interleukins-6 and 8 in pediatric cancer patients with fever and neutropenia.
Haematologica 2004;89(2):234-6.
2004: Matthias Eyrich; Christine Leiler; Tanja Croner; Peter Lang; Michael Schumm; Beate Mascher; Karin Schilbach; Thomas Klingebiel; Rupert Handgretinger; Dietrich Niethammer; Paul G Schlegel
Impaired T-cell activation and cytokine productivity after transplantation of positively selected CD34+ allogeneic hematopoietic stem cells.
The hematology journal : the official journal of the European Haematology Association / EHA 2004;5(4):329-40.
2004: Peter Lang; Thomas Klingebiel; Peter Bader; Johann Greil; Michael Schumm; Paul G Schlegel; Matthias Eyrich; S Mueller-Weihrich; Dietrich Niethammer; Rupert Handgretinger
Transplantation of highly purified peripheral-blood CD34+ progenitor cells from related and unrelated donors in children with nonmalignant diseases.
Bone marrow transplantation 2004;33(1):25-32.
2004: Walter Hoelle; James F Beck; Gregor Dueckers; Hermann Kreyenberg; Peter Lang; Bernd Gruhn; Monika Führer; Dietrich Niethammer; Thomas Klingebiel; Peter Bader
Clinical relevance of serial quantitative analysis of hematopoietic chimerism after allogeneic stem cell transplantation in children for severe aplastic anemia.
Bone marrow transplantation 2004;33(2):219-23.
2004: Thomas Lehrnbecher; Domenica Varwig; J Kaiser; Dirk Reinhardt; Thomas Klingebiel; Ursula Creutzig
Infectious complications in pediatric acute myeloid leukemia: analysis of the prospective multi-institutional clinical trial AML-BFM 93.
Leukemia 2004;18(1):72-7.
2003: O Krejci; V H J van der Velden; Peter Bader; Hermann Kreyenberg; Nicholas J Goulden; J Hancock; M W Schilham; Arjan C Lankester; Tom Révész; Thomas Klingebiel; Jacques J M van Dongen
Level of minimal residual disease prior to haematopoietic stem cell transplantation predicts prognosis in paediatric patients with acute lymphoblastic leukaemia: a report of the Pre-BMT MRD Study Group.
Bone marrow transplantation 2003;32(8):849-51.
2003: Hermann Einsele; Hartmut Bertz; Jörg Beyer; Michael Kiehl; Volker Runde; Hans-Jochen Kolb; Ernst Holler; Robert Beck; Rainer Schwerdfeger; Ulrike Schumacher; Holger Hebart; Hans Martin; Joachim Kienast; Andrew J Ullmann; Georg Maschmeyer; William Krüger; Dietger Niederwieser; Hartmut Link; Christian A Schmidt; Helmut Oettle; Thomas Klingebiel
Infectious complications after allogeneic stem cell transplantation: epidemiology and interventional therapy strategies--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
Annals of hematology 2003;82 Suppl 2():S175-85.
2003: Brunhild Schiltmeyer; Thomas Klingebiel; Matthias Schwab; Thomas E Mürdter; Christoph A Ritter; Andreas Jenke; Gerhard Ehninger; Bernd Gruhn; Gudrun Würthwein; Joachim Boos; Georg Hempel
Population pharmacokinetics of oral busulfan in children.
Cancer chemotherapy and pharmacology 2003;52(3):209-16.
2003: Matthias Eyrich; Christine Leiler; Peter Lang; Karin Schilbach; Michael Schumm; Peter Bader; Johann Greil; Thomas Klingebiel; Rupert Handgretinger; Dietrich Niethammer; Paul G Schlegel
A prospective comparison of immune reconstitution in pediatric recipients of positively selected CD34+ peripheral blood stem cells from unrelated donors vs recipients of unmanipulated bone marrow from related donors.
Bone marrow transplantation 2003;32(4):379-90.
2003: Ziju Elanjikal; Jan Sörensen; Helga Schmidt; Wolfgang Dupuis; Kathrin Tintelnot; Günter Jautzke; Thomas Klingebiel; Thomas Lehrnbecher
Combination therapy with caspofungin and liposomal amphotericin B for invasive aspergillosis.
The Pediatric infectious disease journal 2003;22(7):653-6.
2003: K Junker; Ulrike Koehl; S Zimmerman; S Stein; Dirk Schwabe; Thomas Klingebiel; Manuel Grez
Kinetics of cell death in T lymphocytes genetically modified with two novel suicide fusion genes.
Gene therapy 2003;10(14):1189-97.
2003: Nicholas J Goulden; Peter Bader; V H J van der Velden; John Moppett; Marco Schilham; Hans O Masden; Ondrej Krejci; Hermann Kreyenberg; Arjan C Lankester; Tom Révész; Thomas Klingebiel; Jacques Van Dongen
Minimal residual disease prior to stem cell transplant for childhood acute lymphoblastic leukaemia.
British journal of haematology 2003;122(1):24-9.
2003: Wolfhart Kreuz; Carmen Escuriola Ettingshausen; Günter Auerswald; Inmaculada Martinez Saguer; Sabine Becker; Markus Funk; Christine Heller; Dieter Klarmann; Thomas Klingebiel
Epidemiology of inhibitors and current treatment strategies.
Haematologica 2003;88(6):EREP04.
2003: Anja Borgmann; Arend von Stackelberg; Reinhard Hartmann; Wolfram Ebell; Thomas Klingebiel; Christina Peters; Günter Henze
Unrelated donor stem cell transplantation compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission: a matched-pair analysis.
Blood 2003;101(10):3835-9.
2003: Rouslan Kotchetkov; Jindrich Cinatl; Roman A Blaheta; Jens-Uwe Vogel; Jana Karaskova; Jeremy Squire; Pablo Hernáiz Driever; Thomas Klingebiel; Jindrich Cinatl
Development of resistance to vincristine and doxorubicin in neuroblastoma alters malignant properties and induces additional karyotype changes: a preclinical model.
International journal of cancer. Journal international du cancer 2003;104(1):36-43.
2003: Peter Lang; Rupert Handgretinger; Dietrich Niethammer; Paul G Schlegel; Michael Schumm; Johann Greil; Peter Bader; Corinna Engel; Hans Scheel-Walter; Matthias Eyrich; Thomas Klingebiel
Transplantation of highly purified CD34+ progenitor cells from unrelated donors in pediatric leukemia.
Blood 2003;101(4):1630-6.
2003: Ulrike Koehl; Olaf Beck; Ruth Esser; Erhard Seifried; Thomas Klingebiel; Dirk Schwabe; Christian Seidl
Quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detection: the Frankfurt experience.
Leukemia 2003;17(1):232-6.
2002: Bernhard Kremens; Bernd Gruhn; Thomas Klingebiel; Carola Hasan; Hans-Jürgen Laws; Ewa Koscielniak; Barbara Hero; Barbara Selle; Charlotte Niemeyer; F G Finckenstein; A Schulz; A Wawer; F Zintl; Norbert Graf
High-dose chemotherapy with autologous stem cell rescue in children with nephroblastoma.
Bone marrow transplantation 2002;30(12):893-8.
2002: Tobias Eckle; P Lang; Lothar Prix; Gerhard Jahn; Thomas Klingebiel; Rupert Handgretinger; B Selle; D Niethammer; Klaus Hamprecht
Rapid development of ganciclovir-resistant cytomegalovirus infection in children after allogeneic stem cell transplantation in the early phase of immune cell recovery.
Bone marrow transplantation 2002;30(7):433-9.
2002: Peter Bader; J Hancock; Hermann Kreyenberg; Nicholas J Goulden; Dietrich Niethammer; Anthony Oakhill; Colin Steward; Rupert Handgretinger; James F Beck; Thomas Klingebiel
Minimal residual disease (MRD) status prior to allogeneic stem cell transplantation is a powerful predictor for post-transplant outcome in children with ALL.
Leukemia 2002;16(9):1668-72.
2002: Matthias Eyrich; Tanja Croner; Christine Leiler; Peter Lang; Peter Bader; Thomas Klingebiel; Dietrich Niethammer; Paul G Schlegel
Distinct contributions of CD4(+) and CD8(+) naive and memory T-cell subsets to overall T-cell-receptor repertoire complexity following transplantation of T-cell-depleted CD34-selected hematopoietic progenitor cells from unrelated donors.
Blood 2002;100(5):1915-8.
2002: James F Beck; Thomas Klingebiel; Hermann Kreyenberg; A Schaudt; W Wölle; Dietrich Niethammer; Peter Bader
[Relapse of childhood ALL, AML and MDS after allogeneic stem cell transplantation can be prevented by donor lymphocyte infusion in a critical stage of increasing mixed chimerism].
Klinische Pädiatrie 2002;214(4):201-5.
2002: Josef Vormoor; Thomas Klingebiel; Heribert Jürgens
[Current state of cord blood transplantation in childhood].
Klinische Pädiatrie 2002;214(4):195-200.
2002: Wolfhart Kreuz; Carmen Escuriola Ettingshausen; Alex Zyschka; Johannes Oldenburg; Inmaculada Martinez Saguer; Silke Ehrenforth; Thomas Klingebiel
Inhibitor development in previously untreated patients with hemophilia A: a prospective long-term follow-up comparing plasma-derived and recombinant products.
Seminars in thrombosis and hemostasis 2002;28(3):285-90.
2002: Stefanie-Yvonne Zimmermann; Thomas Klingebiel; Ulrike Koehl; J Soerensen; Dirk Schwabe
Tecelac as antithymocyte globulin in conditioning for childhood allogeneic stem cell transplantation.
Bone marrow transplantation 2002;29(12):957-62.
2002: Ulrike Koehl; Stefanie-Yvonne Zimmermann; Ruth Esser; Jan Sörensen; Hans-Peter Grüttner; M Duchscherer; Erhard Seifried; Thomas Klingebiel; Dirk Schwabe
Autologous transplantation of CD133 selected hematopoietic progenitor cells in a pediatric patient with relapsed leukemia.
Bone marrow transplantation 2002;29(11):927-30.
2002: Rupert Handgretinger; Peter Lang; K Ihm; Michael Schumm; A Geiselhart; Ewa Koscielniak; Barbara Hero; Thomas Klingebiel; Dietrich Niethammer
Isolation and transplantation of highly purified autologous peripheral CD34(+) progenitor cells: purging efficacy, hematopoietic reconstitution and long-term outcome in children with high-risk neuroblastoma.
Bone marrow transplantation 2002;29(9):731-6.
2002: Peter Lang; Matthias Pfeiffer; Rupert Handgretinger; Michael Schumm; B Demirdelen; S Stanojevic; Thomas Klingebiel; U Köhl; Selim Kuci; Dietrich Niethammer
Clinical scale isolation of T cell-depleted CD56+ donor lymphocytes in children.
Bone marrow transplantation 2002;29(6):497-502.
2002: Markus B Funk; H Schmidt; Sabine Becker; C Escuriola; Dieter Klarmann; Thomas Klingebiel; Wolfhart Kreuz
Modified magnetic resonance imaging score compared with orthopaedic and radiological scores for the evaluation of haemophilic arthropathy.
Haemophilia : the official journal of the World Federation of Hemophilia 2002;8(2):98-103.
2002: Peter Bader; G Dückers; Hermann Kreyenberg; Walter Hoelle; Gunter Kerst; Peter Lang; Johann Greil; Dietrich Niethammer; L F Beck; Thomas Klingebiel
Monitoring of donor cell chimerism for the detection of relapse and early immunotherapeutic intervention in acute lymphoblastic leukemias.
Annals of hematology 2002;81 Suppl 2():S25-7.
2002: Gudrun Würthwein; Thomas Klingebiel; Sebastian Krümpelmann; Melanie Metz; Kerstin Schwenker; Karen Kranz; Claudia Lanvers; Joachim Boos
Population pharmacokinetics of high-dose etoposide in children receiving different conditioning regimens.
Anti-cancer drugs 2002;13(1):101-10.
2001: Michael Günter; Michael Karle; Thomas Klingebiel
Psychosocial care in children with stem cell transplantation.
Bone marrow transplantation 2001;28 Suppl 1():S25-8.
2001: Matthias Eyrich; Peter Lang; S Lal; Peter Bader; Rupert Handgretinger; Thomas Klingebiel; Dietrich Niethammer; Paul G Schlegel
A prospective analysis of the pattern of immune reconstitution in a paediatric cohort following transplantation of positively selected human leucocyte antigen-disparate haematopoietic stem cells from parental donors.
British journal of haematology 2001;114(2):422-32.
2001: I Müller; Christian Aepinus; R Beck; Burkhard D Bültmann; Dietrich Niethammer; Thomas Klingebiel
Noncutaneous varicella-zoster virus (VZV) infection with fatal liver failure in a child with acute lymphoblastic leukemia (ALL).
Medical and pediatric oncology 2001;37(2):145-7.
2001: Rupert Handgretinger; Peter Lang; Michael Schumm; Matthias Pfeiffer; S Gottschling; B Demirdelen; Peter Bader; Selim Kuci; Thomas Klingebiel; Dietrich Niethammer
Immunological aspects of haploidentical stem cell transplantation in children.
Annals of the New York Academy of Sciences 2001;938():340-57; discussion 357-8.
2001: Richard Linde; Markus B Funk; Tobias Schuster; Uwe Wintergerst; Gundula Notheis; Thomas Klingebiel; Wolfhart Kreuz
Low incidence of genotypic and phenotypic resistance in paediatric HIV-infected patients on long-term first-line antiretroviral triple therapy.
AIDS (London, England) 2001;15(8):1077-9.
2001: Rupert Handgretinger; Thomas Klingebiel; Peter Lang; Michael Schumm; S Neu; A Geiselhart; Peter Bader; Paul G Schlegel; Johann Greil; D Stachel; R J Herzog; Dietrich Niethammer
Megadose transplantation of purified peripheral blood CD34(+) progenitor cells from HLA-mismatched parental donors in children.
Bone marrow transplantation 2001;27(8):777-83.
2000: Susanne Renner; S Krümpelmann; Gernot Bruchelt; H Wiesinger; Dietrich Niethammer; Thomas Klingebiel
Effect of amifostine on neuroblastoma during high dose chemotherapy: in vivo and in vitro investigations.
Anticancer research 2000;20(6B):4531-8.
2000: Paul G Schlegel; Matthias Eyrich; Peter Bader; Rupert Handgretinger; Peter Lang; Dietrich Niethammer; Thomas Klingebiel
OKT-3-based reconditioning regimen for early graft failure in HLA-non-identical stem cell transplants.
British journal of haematology 2000;111(2):668-73.
2000: Holger Hebart; Jürgen Löffler; H Reitze; A Engel; Ulrike Schumacher; Thomas Klingebiel; Peter Bader; A Böhme; H Martin; D Bunjes; WV Kern; Lothar Kanz; Hermann Einsele
Prospective screening by a panfungal polymerase chain reaction assay in patients at risk for fungal infections: implications for the management of febrile neutropenia.
British journal of haematology 2000;111(2):635-40.
2000: Tobias Eckle; Lothar Prix; Gerhard Jahn; Thomas Klingebiel; Rupert Handgretinger; B Selle; Klaus Hamprecht
Drug-resistant human cytomegalovirus infection in children after allogeneic stem cell transplantation may have different clinical outcomes.
Blood 2000;96(9):3286-9.
2000: Hellmut D Ottinger; C Müller; Norbert Schmitz; B Kubanek; Renate Arnold; Wolfram Ebell; H P Eberhard; Gerhard Ehninger; U Fronz; Shraga F Goldmann; Hans Grosse-Wilde; Werner Havers; Thomas Klingebiel; Hans-Jochem Kolb; Siegfried Seeber; Ulrich W Schaefer; H Baldomero; Alois Gratwohl
Transplant activities in Germany in 1998--a survey facilitated by the National Registry for Hemopoietic Stem Cell Transplantation.
Annals of hematology 2000;79(8):437-43.
2000: Christina Peters; Milen Minkov; Helmut Gadner; Thomas Klingebiel; Jaak Vossen; Franco Locatelli; J Cornish; Juan Ortega; A Bekasi; G Souillet; Jan Stary; D Niethammer
Statement of current majority practices in graft-versus-host disease prophylaxis and treatment in children.
Bone marrow transplantation 2000;26(4):405-11.
2000: Hermann Einsele; Holger Hebart; C Kauffmann-Schneider; Christian Sinzger; Gerhard Jahn; Peter Bader; Thomas Klingebiel; K Dietz; Jürgen Löffler; C Bokemeyer; CA Müller; Lothar Kanz
Risk factors for treatment failures in patients receiving PCR-based preemptive therapy for CMV infection.
Bone marrow transplantation 2000;25(7):757-63.
2000: Peter Bader; K Stoll; S Huber; A Geiselhart; Rupert Handgretinger; Charlotte Niemeyer; H Einsele; Paul G Schlegel; Dietrich Niethammer; J Beck; Thomas Klingebiel
Characterization of lineage-specific chimaerism in patients with acute leukaemia and myelodysplastic syndrome after allogeneic stem cell transplantation before and after relapse.
British journal of haematology 2000;108(4):761-8.
2000: Hans P Haber; Paul G Schlegel; S Dette; Peter Ruck; Thomas Klingebiel; Dietrich Niethammer
Intestinal acute graft-versus-host disease: findings on sonography.
AJR. American journal of roentgenology 2000;174(1):118-20.
1999: Peter Bader; Thomas Klingebiel; A Schaudt; U Theurer-Mainka; Rupert Handgretinger; Peter Lang; Dietrich Niethammer; James F Beck
Prevention of relapse in pediatric patients with acute leukemias and MDS after allogeneic SCT by early immunotherapy initiated on the basis of increasing mixed chimerism: a single center experience of 12 children.
Leukemia 1999;13(12):2079-86.
1999: Christina Peters; Susanne Matthes-Martin; Gerhard Fritsch; Wolfgang Holter; Thomas Lion; V Witt; Paul Höcker; G Fischer; K Dieckmann; R Handgretinger; Thomas Klingebiel; Helmut Gadner
Transplantation of highly purified peripheral blood CD34+ cells from HLA-mismatched parental donors in 14 children: evaluation of early monitoring of engraftment.
Leukemia 1999;13(12):2070-8.
1999: Alfred Reiter; Martin Schrappe; Markus Tiemann; Wolf-Dieter Ludwig; E Yakisan; Martin Zimmermann; Georg Mann; A Chott; Wolfram Ebell; Thomas Klingebiel; Norbert Graf; Bernhard Kremens; S Müller-Weihrich; H J Plüss; Felix Zintl; Günter Henze; Hansjörg Riehm
Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.
Blood 1999;94(10):3294-306.
1999: Peter Lang; Michael Schumm; G Taylor; Thomas Klingebiel; S Neu; A Geiselhart; Selim Kuci; Dietrich Niethammer; Rupert Handgretinger
Clinical scale isolation of highly purified peripheral CD34+progenitors for autologous and allogeneic transplantation in children.
Bone marrow transplantation 1999;24(6):583-9.
1999: Christina Peters; Milen Minkov; Susanne Matthes-Martin; Ulrike Pötschger; V Witt; Georg Mann; Paul Höcker; Nina Worel; Jan Stary; Thomas Klingebiel; Helmut Gadner
Leucocyte transfusions from rhG-CSF or prednisolone stimulated donors for treatment of severe infections in immunocompromised neutropenic patients.
British journal of haematology 1999;106(3):689-96.
1999: Lothar Prix; Klaus Hamprecht; B Holzhüter; Rupert Handgretinger; Thomas Klingebiel; Gerhard Jahn
Comprehensive restriction analysis of the UL97 region allows early detection of ganciclovir-resistant human cytomegalovirus in an immunocompromised child.
The Journal of infectious diseases 1999;180(2):491-5.
1999: Rupert Handgretinger; Michael Schumm; Peter Lang; Johann Greil; A Reiter; Peter Bader; Dietrich Niethammer; Thomas Klingebiel
Transplantation of megadoses of purified haploidentical stem cells.
Annals of the New York Academy of Sciences 1999;872():351-61; discussion 361-2.
1999: Susanne Renner; Thomas Klingebiel; Dietrich Niethammer; Gernot Bruchelt; T Meissner; F Eisenbeiss
Isotachophoretic determination of phosphate splitting from Amifostine and p-nitrophenyl phosphate in serum and neuroblastoma cells.
Journal of chromatography. A 1999;838(1-2):251-7.
1999: Michael Schumm; Peter Lang; G Taylor; Selim Kuçi; Thomas Klingebiel; Hans-Jörg Bühring; A Geiselhart; Dietrich Niethammer; Rupert Handgretinger
Isolation of highly purified autologous and allogeneic peripheral CD34+ cells using the CliniMACS device.
Journal of hematotherapy 1999;8(2):209-18.
1999: E I Mayer; R E Dopfer; Thomas Klingebiel; H Scheel-Walter; Michael B Ranke; Dietrich Niethammer
Longitudinal gonadal function after bone marrow transplantation for acute lymphoblastic leukemia during childhood.
Pediatric transplantation 1999;3(1):38-44.
1999: Michael Günter; Michael Karle; A Werning; Thomas Klingebiel
Emotional adaptation of children undergoing bone marrow transplantation.
Canadian journal of psychiatry. Revue canadienne de psychiatrie 1999;44(1):77-81.
1999: A Wiesmann; A Weller; G Lischka; Thomas Klingebiel; Lothar Kanz; Hermann Einsele
Treatment of acute graft-versus-host disease with PUVA (psoralen and ultraviolet irradiation): results of a pilot study.
Bone marrow transplantation 1999;23(2):151-5.
1999: P Reuland; E Kaiserling; Thomas Klingebiel; U Feine; Dietrich Niethammer
Differential diagnosis of metastases in bone scans: chemotherapy induced bone necrosis.
Nuklearmedizin. Nuclear medicine 1999;38(2):38-42.
1998: Jürgen Löffler; Holger Hebart; S Sepe; U Schumcher; Thomas Klingebiel; Hermann Einsele
Detection of PCR-amplified fungal DNA by using a PCR-ELISA system.
Medical mycology : official publication of the International Society for Human and Animal Mycology 1998;36(5):275-9.
1998: Christina Peters; R Ladenstein; Milen Minkov; Ulrike Pötschger; Helmut Gadner; J Cornish; G Dini; Thomas Klingebiel; Franco Locatelli; Jaak Vossen; D Niethammer
Transplantation activities and treatment strategies in paediatric stem cell transplantation centres: a report from the EBMT Working Party on Paediatric Diseases. European Group for Blood and Marrow Transplantation.
Bone marrow transplantation 1998;22(5):431-7.
1998: Thomas Klingebiel; Peter Bader; Roland Bares; J Beck; Barbara Hero; H Jürgens; Peter Lang; Dietrich Niethammer; B Rath; Rupert Handgretinger
Treatment of neuroblastoma stage 4 with 131I-meta-iodo-benzylguanidine, high-dose chemotherapy and immunotherapy. A pilot study.
European journal of cancer (Oxford, England : 1990) 1998;34(9):1398-402.
1998: Monika Führer; Stefan Burdach; Wolfram Ebell; Helmut Gadner; R Haas; Jochen Harbott; Gritta E Janka-Schaub; Thomas Klingebiel; Bernhard Kremens; Charlotte Niemeyer; Udo Rampf; Alfred Reiter; Jörg Ritter; A Schulz; U Walther; Cornelia Zeidler; Christine Bender-Götze
Relapse and clonal disease in children with aplastic anemia (AA) after immunosuppressive therapy (IST): the SAA 94 experience. German/Austrian Pediatric Aplastic Anemia Working Group.
Klinische Pädiatrie 1998;210(4):173-9.
1998: Rupert Handgretinger; Peter Lang; Michael Schumm; G Taylor; S Neu; E Koscielnak; Dietrich Niethammer; Thomas Klingebiel
Isolation and transplantation of autologous peripheral CD34+ progenitor cells highly purified by magnetic-activated cell sorting.
Bone marrow transplantation 1998;21(10):987-93.
1998: Thomas Klingebiel; U Pertl; C F Hess; H Jürgens; Ewa Koscielniak; R Pötter; R van Heek-Romanowski; Rainer Rossi; C Schött; H J Spaar; U Willnow; Jörn Treuner
Treatment of children with relapsed soft tissue sarcoma: report of the German CESS/CWS REZ 91 trial.
Medical and pediatric oncology 1998;30(5):269-75.
1998: Christina Peters; Milen Minkov; Helmut Gadner; Thomas Klingebiel; D Niethammer
Proposal for standard recommendations for prophylaxis of graft-versus-host disease in children. European Group for Blood and Marrow Transplantation (EBMT) Working Party Paediatric Diseases and the International Study Committee of the BFM family-subcommittee Bone Marrow Transplantation (IBFM-STG).
Bone marrow transplantation 1998;21 Suppl 2():S57-60.
1998: Thomas Klingebiel; Paul G Schlegel
GVHD: overview on pathophysiology, incidence, clinical and biological features.
Bone marrow transplantation 1998;21 Suppl 2():S45-9.
1998: Peter Bader; J Beck; A Frey; Paul G Schlegel; H Hebarth; Rupert Handgretinger; H Einsele; Charlotte Niemeyer; N Benda; C Faul; L Kanz; Dietrich Niethammer; Thomas Klingebiel
Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT.
Bone marrow transplantation 1998;21(5):487-95.
1998: Paul G Schlegel; Hans P Haber; J Beck; S Krümpelmann; R Handgretinger; Peter Bader; M Bierings; Dietrich Niethammer; Thomas Klingebiel
Hepatic veno-occlusive disease in pediatric stem cell recipients: successful treatment with continuous infusion of prostaglandin E1 and low-dose heparin.
Annals of hematology 1998;76(1):37-41.
1997: Barbara Hero; Bernhard Kremens; Thomas Klingebiel; Christine Bender-Götze; Stefan Burdach; M Schrappe; F Berthold
Does megatherapy contribute to survival in metastatic neuroblastoma? A retrospective analysis. German Cooperative Neuroblastoma Study Group.
Klinische Pädiatrie 1997;209(4):196-200.
1997: Hellmut D Ottinger; E Albert; Renate Arnold; D W Beelen; R Blasczyk; D Bunjes; Stefan Burdach; Wolfram Ebell; Gerhard Ehninger; H Einsele; Jürgen Enczmann; Axel A Fauser; W Friedrich; J Finke; Ulrich Göbel; Shraga F Goldmann; M Gramatzki; Werner Helbig; L Kanz; Thomas Klingebiel; Hans-Jochem Kolb; P Kühnl; C Löliger; C R Müller; Hans Grosse-Wilde
German consensus on immunogenetic donor search for transplantation of allogeneic bone marrow and peripheral blood stem cells.
Bone marrow transplantation 1997;20(2):101-5.
1997: Peter Bader; J Beck; Paul G Schlegel; Rupert Handgretinger; Dietrich Niethammer; Thomas Klingebiel
Additional immunotherapy on the basis of increasing mixed hematopoietic chimerism after allogeneic BMT in children with acute leukemia: is there an option to prevent relapse?
Bone marrow transplantation 1997;20(1):79-81.
1997: Rupert Handgretinger; Johann Greil; U Schürmann; Peter Lang; O Gonzalez-Ramella; I Schmidt; R Führer; Dietrich Niethammer; Thomas Klingebiel
Positive selection and transplantation of peripheral CD34+ progenitor cells: feasibility and purging efficacy in pediatric patients with neuroblastoma.
Journal of hematotherapy 1997;6(3):235-42.
1997: Holger Hebart; A Schröder; Jürgen Löffler; Thomas Klingebiel; H Martin; B Wassmann; F Gerneth; H Rabenau; Gerhard Jahn; Lothar Kanz; CA Müller; Hermann Einsele
Cytomegalovirus monitoring by polymerase chain reaction of whole blood samples from patients undergoing autologous bone marrow or peripheral blood progenitor cell transplantation.
The Journal of infectious diseases 1997;175(6):1490-3.
1997: Peter Bader; W Hölle; Thomas Klingebiel; Rupert Handgretinger; N Benda; Paul G Schlegel; Dietrich Niethammer; J Beck
Mixed hematopoietic chimerism after allogeneic bone marrow transplantation: the impact of quantitative PCR analysis for prediction of relapse and graft rejection in children.
Bone marrow transplantation 1997;19(7):697-702.
1997: Franco Locatelli; Charlotte Niemeyer; Emanuele Angelucci; Christine Bender-Götze; Stefan Burdach; Wolfram Ebell; W Friedrich; Henrik Hasle; Johann Hermann; N Jacobsen; Thomas Klingebiel; Bernhard Kremens; Georg Mann; Andrea Pession; Christina Peters; H J Schmid; Jan Stary; Meinolf Suttorp; Cornelio Uderzo; E T van't Veer-Korthof; Jaak Vossen; Marco Zecca; Martin Zimmermann
Allogeneic bone marrow transplantation for chronic myelomonocytic leukemia in childhood: a report from the European Working Group on Myelodysplastic Syndrome in Childhood.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(2):566-73.
1997: Ewa Koscielniak; Thomas Klingebiel; Christina Peters; J Hermann; S T Burdach; Christine Bender-Götze; ST Müller-Weihrich; Jörn Treuner
Do patients with metastatic and recurrent rhabdomyosarcoma benefit from high-dose therapy with hematopoietic rescue? Report of the German/Austrian Pediatric Bone Marrow Transplantation Group.
Bone marrow transplantation 1997;19(3):227-31.
1997: J E Hoppe; M Klausner; Thomas Klingebiel; Dietrich Niethammer
Retrospective analysis of yeast colonization and infections in paediatric bone marrow transplant recipients.
Mycoses 1997;40(1-2):47-54.
1996: Franco Locatelli; Marco Zecca; C Niemeyer; E Angelucci; G Arcese; C Bender-Gotze; Federico Bonetti; Stefan Burdach; G Dini; Wolfram Ebell; W Friedrich; H Hasle; J Hermann; N Jacobsen; Thomas Klingebiel; Bernhard Kremens; Georg Mann; Roberto Miniero; Andrea Pession; Christina Peters; P Paolucci; Flavio Rossetti; H J Schmid; Jan Stary; M Zimmermann
Role of allogeneic bone marrow transplantation for the treatment of myelodysplastic syndromes in childhood. The European Working Group on Childhood Myelodysplastic Syndrome (EWOG-MDS) and the Austria-Germany-Italy (AGI) Bone Marrow Transplantation Registry.
Bone marrow transplantation 1996;18 Suppl 2():63-8.
1996: Thomas Klingebiel; A Pession; P Paolucci; Roberto Rondelli
Autologous versus allogeneic BMT in AML: the European experience. Report of the EBMT--Pediatric Diseases Working Party.
Bone marrow transplantation 1996;18 Suppl 2():49-52.
1996: Christina Peters; R Ladenstein; W Ochsenreiter; Ulrike Pötschger; Helmut Gadner; G Dini; Thomas Klingebiel; F Locatelli; J Vossen; Dietrich Niethammer
Survey of supportive care standards for paediatric allogeneic stem cell transplantation patients in Europe: a first report from the EBMT Paediatric Diseases Working Party.
Bone marrow transplantation 1996;18 Suppl 2():17-24.
1996: P Reuland; K P Aicher; R Dopfer; R Handgretinger; Thomas Klingebiel; D Niethammer
[Differential diagnosis of childhood osteomyelitis--classification according to scintigraphic, radiologic and magnetic resonance tomographic characteristics].
Nuklearmedizin. Nuclear medicine 1996;35(3):68-77.
1996: Frank Berthold; Barbara Hero; H Breu; Holger Christiansen; R Erttmann; A Gnekow; F Herrmann; Thomas Klingebiel; Fritz H Lampert; S Müller-Weihrich; Peter Weinel
The recurrence patterns of stages I, II and III neuroblastoma: experience with 77 relapsing patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(2):183-7.
1995: Hermann Einsele; Gerhard Ehninger; Holger Hebart; Knut M Wittkowski; Ulrich Schuler; Gerhard Jahn; P Mackes; M Herter; Thomas Klingebiel; Jürgen Löffler; S Wagner; CA Müller
Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation.
Blood 1995;86(7):2815-20.
1995: Thomas Klingebiel; Rupert Handgretinger; M Herter; T Eppinger; Peter Bader; Peter Lang; R Dopfer; H Scheel-Walter; U Haus; Dietrich Niethammer
Autologous transplantation with peripheral blood stem cells in children and young adults after myeloablative treatment: nonrandomized comparison between GM-CSF and G-CSF for mobilization.
Journal of hematotherapy 1995;4(4):307-14.
1994: R Ladenstein; Christine Lasset; Olivier Hartmann; Thomas Klingebiel; E Bouffet; Helmut Gadner; P Paolucci; S Burdach; Franck Chauvin; Ross Pinkerton
Comparison of auto versus allografting as consolidation of primary treatments in advanced neuroblastoma over one year of age at diagnosis: report from the European Group for Bone Marrow Transplantation.
Bone marrow transplantation 1994;14(1):37-46.
1994: Thomas Klingebiel; Rupert Handgretinger; M Herter; Peter Lang; R Dopfer; H Scheel-Walter; Dietrich Niethammer
Peripheral stem cell transplantation in neuroblastoma stage 4 with the use of [131I-m]IBG.
Progress in clinical and biological research 1994;385():309-17.
1994: Bernhard Kremens; Thomas Klingebiel; F Herrmann; Christine Bender-Götze; Stefan Burdach; W Ebell; W Friedrich; E Koscielniak; H Schmid; W Siegert
High-dose consolidation with local radiation and bone marrow rescue in patients with advanced neuroblastoma.
Medical and pediatric oncology 1994;23(6):470-5.
1994: Rupert Handgretinger; Thomas Klingebiel; M Herter; Peter Lang; A Gisselhart; R Dopfer; H Scheel-Walter; H Ehrlich; Dietrich Niethammer
Comparative analysis of peripheral stem cells collected and transplanted in combination with granulocyte-macrophage and granulocyte colony-stimulating factors.
Progress in clinical and biological research 1994;389():479-86.
1993: R Ladenstein; Christine Lasset; Olivier Hartmann; D Frappaz; Alberto Garaventa; Thomas Klingebiel; J M Zucker; C Coze; S Burdach; Helmut Gadner
Impact of megatherapy on survival after relapse from stage 4 neuroblastoma in patients over 1 year of age at diagnosis: a report from the European Group for Bone Marrow Transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(12):2330-41.
1993: H P Haber; K Drews; H Scheel-Walter; Thomas Klingebiel
Aneurysmal bone cyst in early childhood. Ultrasound findings.
Pediatric radiology 1993;23(5):405-6.
1992: Thomas Klingebiel; P Reuland; U Feine; Dietrich Niethammer
[Follow-up evaluation of metastatic neuroblastoma using high dose [131I-meta]iodobenzylguanidine].
Nuklearmedizin. Nuclear medicine 1992;31(6):209-12.
1992: Volker Gekeler; G Frese; A Noller; Rupert Handgretinger; A Wilisch; H Schmidt; Claude P Muller; R Dopfer; Thomas Klingebiel; H Diddens
Mdr1/P-glycoprotein, topoisomerase, and glutathione-S-transferase pi gene expression in primary and relapsed state adult and childhood leukaemias.
British journal of cancer 1992;66(3):507-17.
1992: P Reuland; U Feine; Rupert Handgretinger; Edwin Kaiserling; Thomas Klingebiel; D Niethammer
Case report 756: Chronic multifocal osteomyelitis.
Skeletal radiology 1992;21(7):478-81.
1992: Rupert Handgretinger; Thomas Klingebiel; R Dopfer; R Siedner; B Baden; S Wendt; H G Scheel-Walter; P Scheel; M Schlander; Dietrich Niethammer
Peripheral stem cell collection and transplantation in pediatric patients.
Progress in clinical and biological research 1992;377():615-20.
1991: R Dopfer; G Henze; Christine Bender-Götze; Wolfram Ebell; G Ehninger; W Friedrich; H Gadner; Thomas Klingebiel; C Peters; H Riehm
Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission after intensive primary and relapse therapy according to the BFM- and CoALL-protocols: results of the German Cooperative Study.
Blood 1991;78(10):2780-4.
1991: Thomas Klingebiel; U Feine; Jörn Treuner; P Reuland; Rupert Handgretinger; D Niethammer
Treatment of neuroblastoma with [131I]metaiodobenzylguanidine: long-term results in 25 patients.
Journal of nuclear biology and medicine (Turin, Italy : 1991) 1991;35(4):216-9.
1991: Thomas Klingebiel; Gernot Bruchelt; N Kaleva; H Wollmann; Rupert Handgretinger; Jörn Treuner; D Gupta; Dietrich Niethammer
Opioid peptides as possible cause of pain reduction in neuroblastoma after admission of 131I-meta-iodobenzylguanidine.
Progress in clinical and biological research 1991;366():509-12.
1991: Thomas Klingebiel; Gernot Bruchelt; Theodor W Kaulich; H Smykowski; Jörn Treuner; Dietrich Niethammer
Irradiation of human neuroblastoma cell lines by [131I-m]iodobenzylguanidine.
Progress in clinical and biological research 1991;366():487-93.
1991: Thomas Klingebiel; Frank Berthold; Jörn Treuner; D Schwabe; M Fischer; U Feine; F D Maul; W Waters; H Wehinger; Dietrich Niethammer
Metaiodobenzylguanidine (mIBG) in treatment of 47 patients with neuroblastoma: results of the German Neuroblastoma Trial.
Medical and pediatric oncology 1991;19(2):84-8.
1991: P Reuland; Rupert Handgretinger; H Smykowsky; R Dopfer; Thomas Klingebiel; B M Miller; R A Reisfeld; S Gallagher; E Koscelniak; Jörn Treuner
Application of the murine anti-Gd-2 antibody 14.Gd-2a for diagnosis and therapy of neuroblastoma.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1991;18(1):121-5.
1991: Thomas Klingebiel; J Ritter; G Schellong; U Creutzig; H Riehm; G Henze; Christine Bender-Götze; R Dopfer; Wolfram Ebell; W Friedrich
Role and perspectives of BMT in AML: the BFM experience.
Bone marrow transplantation 1991;7 Suppl 3():66-70.
1991: Dietrich Niethammer; Thomas Klingebiel; H Riehm; G Henze; G Schellong; Christine Bender-Götze; R Dopfer; Wolfram Ebell; W Friedrich; R J Haas
Role and perspectives of BMT in ALL: the BFM experience.
Bone marrow transplantation 1991;7 Suppl 3():14-8.
1989: Thomas Klingebiel; A Pickert; R Dopfer; M B Ranke; R Siedner
Unusual course of a Chlamydia pneumonia in an infant with IgG2/IgG4-deficiency.
European journal of pediatrics 1989;148(5):431-4.
1989: Thomas Klingebiel; Jörn Treuner; Gerhard Ehninger; K D Keller; R Dopfer; U Feine; Dietrich Niethammer
[131I]-metaiodobenzylguanidine in the treatment of metastatic neuroblastoma. Clinical, pharmacological and dosimetric aspects.
Cancer chemotherapy and pharmacology 1989;25(2):143-8.
1988: Frank Berthold; U Feine; M Fischer; V Gerein; Thomas Klingebiel; F D Maul; W Waters; H Wehinger; Jörn Treuner
[131(I)-meta-iodobenzylguanidine treatment of 32 children with therapy-refractory neuroblastoma].
Klinische Pädiatrie 1988;200(3):226-9.
1988: Jörn Treuner; V Gerein; Thomas Klingebiel; D Schwabe; U Feine; J Happ; Dietrich Niethammer; F Maul; R Dopfer; Bernhard Kornhuber
MIBG-treatment in neuroblastoma; experiences of the Tübingen/Frankfurt group.
Progress in clinical and biological research 1988;271():669-78.
1987: U Feine; W Müller-Schauenburg; Jörn Treuner; Thomas Klingebiel
Metaiodobenzylguanidine (MIBG) labeled with 123I/131I in neuroblastoma diagnosis and follow-up treatment with a review of the diagnostic results of the International Workshop of Pediatric Oncology held in Rome, September 1986.
Medical and pediatric oncology 1987;15(4):181-7.
1986: Thomas Klingebiel; U Feine; Dietrich Niethammer; W Müller-Schauenburg; D Schwabe; F D Maul; V Gerein; M Fischer; M Gahr; K Kraz
[Initial experiences in the treatment of children with metastatic and recurrent neuroblastoma using meta-iodobenzylguanidine].
Klinische Pädiatrie 1986;198(3):230-6.